Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Kei Tsukamoto

Tokyo Women's Medical University, Tokyo (Japan)

9 More presentations in this session

Presentation thumbnail

Effect of beta-blockers on mortality in heart failure with mid-range and preserved ejection fraction: a meta-analysis

Associate Professor H. Fukuta (Nagoya, JP)

Presentation thumbnail

Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction

Professor L. Tumasyan (Yerevan, AM)

Abstract Slides

Presentation thumbnail

The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction

Doctor C. Wei-Ting (Tainan, TW)

Abstract Slides

Presentation thumbnail

Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.

Professor J. Spinar (Brno, CZ)

Abstract Slides

Presentation thumbnail

Rehospitalization burden in heart failure with mid-range ejection fraction and morbidity burden. Is it a distinct phenotype?

Doctor E. Santas Olmeda (Valencia, ES)

Access the full session

Session thumbnail

Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Congress Presentation

Audience Q&A

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources